255 related articles for article (PubMed ID: 11601895)
21. Improved neuronal transgene expression from an AAV-2 vector with a hybrid CMV enhancer/PDGF-beta promoter.
Wang CY; Guo HY; Lim TM; Ng YK; Neo HP; Hwang PY; Yee WC; Wang S
J Gene Med; 2005 Jul; 7(7):945-55. PubMed ID: 15756650
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of adenovirus cytotoxicity, replication, and E2a gene expression by adeno-associated virus.
Jing XJ; Kalman-Maltese V; Cao X; Yang Q; Trempe JP
Virology; 2001 Dec; 291(1):140-51. PubMed ID: 11878883
[TBL] [Abstract][Full Text] [Related]
23. A high-capacity, capsid-modified hybrid adenovirus/adeno-associated virus vector for stable transduction of human hematopoietic cells.
Shayakhmetov DM; Carlson CA; Stecher H; Li Q; Stamatoyannopoulos G; Lieber A
J Virol; 2002 Feb; 76(3):1135-43. PubMed ID: 11773389
[TBL] [Abstract][Full Text] [Related]
24. Heart muscle-specific gene expression using replication defective recombinant adenovirus.
Rothmann T; Katus HA; Hartong R; Perricaudet M; Franz WM
Gene Ther; 1996 Oct; 3(10):919-26. PubMed ID: 8908506
[TBL] [Abstract][Full Text] [Related]
25. Development of a size-restricted pIX-deleted helper virus for amplification of helper-dependent adenovirus vectors.
Sargent KL; Ng P; Evelegh C; Graham FL; Parks RJ
Gene Ther; 2004 Mar; 11(6):504-11. PubMed ID: 14999222
[TBL] [Abstract][Full Text] [Related]
26. [Capsid assembly and DNA encapsidation of adeno-associated virus].
Wang Q; Lü Y; Li Z; Diao Y; Xu R
Sheng Wu Gong Cheng Xue Bao; 2011 Apr; 27(4):531-8. PubMed ID: 21847986
[TBL] [Abstract][Full Text] [Related]
27. Inverted terminal repeat sequences are important for intermolecular recombination and circularization of adeno-associated virus genomes.
Yan Z; Zak R; Zhang Y; Engelhardt JF
J Virol; 2005 Jan; 79(1):364-79. PubMed ID: 15596830
[TBL] [Abstract][Full Text] [Related]
28. Cardio-specific long-term gene expression in a porcine model after selective pressure-regulated retroinfusion of adeno-associated viral (AAV) vectors.
Raake PW; Hinkel R; Müller S; Delker S; Kreuzpointner R; Kupatt C; Katus HA; Kleinschmidt JA; Boekstegers P; Müller OJ
Gene Ther; 2008 Jan; 15(1):12-7. PubMed ID: 17943147
[TBL] [Abstract][Full Text] [Related]
29. Transduction of myogenic cells by retargeted dual high-capacity hybrid viral vectors: robust dystrophin synthesis in duchenne muscular dystrophy muscle cells.
Gonçalves MA; Holkers M; Cudré-Mauroux C; van Nierop GP; Knaän-Shanzer S; van der Velde I; Valerio D; de Vries AA
Mol Ther; 2006 May; 13(5):976-86. PubMed ID: 16443396
[TBL] [Abstract][Full Text] [Related]
30. Self-complementary recombinant adeno-associated viral vectors: packaging capacity and the role of rep proteins in vector purity.
Wu J; Zhao W; Zhong L; Han Z; Li B; Ma W; Weigel-Kelley KA; Warrington KH; Srivastava A
Hum Gene Ther; 2007 Feb; 18(2):171-82. PubMed ID: 17328683
[TBL] [Abstract][Full Text] [Related]
31. Self-complementary adeno-associated virus 2 (AAV)-T cell protein tyrosine phosphatase vectors as helper viruses to improve transduction efficiency of conventional single-stranded AAV vectors in vitro and in vivo.
Zhong L; Chen L; Li Y; Qing K; Weigel-Kelley KA; Chan RJ; Yoder MC; Srivastava A
Mol Ther; 2004 Nov; 10(5):950-7. PubMed ID: 15509512
[TBL] [Abstract][Full Text] [Related]
32. [Recombinant adeno-associated virus vector related impurities].
Diao Y; Wang Q; Xiao W; Xu R
Sheng Wu Gong Cheng Xue Bao; 2011 May; 27(5):717-23. PubMed ID: 21845838
[TBL] [Abstract][Full Text] [Related]
33. Efficient mouse airway transduction following recombination between AAV vectors carrying parts of a larger gene.
Halbert CL; Allen JM; Miller AD
Nat Biotechnol; 2002 Jul; 20(7):697-701. PubMed ID: 12089554
[TBL] [Abstract][Full Text] [Related]
34. A novel adenovirus-adeno-associated virus hybrid vector that displays efficient rescue and delivery of the AAV genome.
Fisher KJ; Kelley WM; Burda JF; Wilson JM
Hum Gene Ther; 1996 Nov; 7(17):2079-87. PubMed ID: 8934222
[TBL] [Abstract][Full Text] [Related]
35. Adeno-associated virus serotypes: vector toolkit for human gene therapy.
Wu Z; Asokan A; Samulski RJ
Mol Ther; 2006 Sep; 14(3):316-27. PubMed ID: 16824801
[TBL] [Abstract][Full Text] [Related]
36. Delivering Transgenic DNA Exceeding the Carrying Capacity of AAV Vectors.
Hirsch ML; Wolf SJ; Samulski RJ
Methods Mol Biol; 2016; 1382():21-39. PubMed ID: 26611576
[TBL] [Abstract][Full Text] [Related]
37. Expressing Transgenes That Exceed the Packaging Capacity of Adeno-Associated Virus Capsids.
Chamberlain K; Riyad JM; Weber T
Hum Gene Ther Methods; 2016 Feb; 27(1):1-12. PubMed ID: 26757051
[TBL] [Abstract][Full Text] [Related]
38. Adeno-associated virus vectors for short hairpin RNA expression.
Grimm D; Pandey K; Kay MA
Methods Enzymol; 2005; 392():381-405. PubMed ID: 15644194
[TBL] [Abstract][Full Text] [Related]
39. Packaging capacity of adeno-associated virus serotypes: impact of larger genomes on infectivity and postentry steps.
Grieger JC; Samulski RJ
J Virol; 2005 Aug; 79(15):9933-44. PubMed ID: 16014954
[TBL] [Abstract][Full Text] [Related]
40. Efficient gene transfer to periodontal ligament cells and human gingival fibroblasts by adeno-associated virus vectors.
Kunze M; Huber A; Krajewski A; Lowden E; Schuhmann N; Buening H; Hallek M; Noack M; Perabo L
J Dent; 2009 Jul; 37(7):502-8. PubMed ID: 19362764
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
